Webcast
The Journey Toward Paperless Clinical Trials
To view the media player you will need Adobe Flash!
Download Adobe Flash
Download Adobe Flash
The video player is loading...
Pharma companies are seeking to bolster pipelines and cut costs more than ever before in preparation for looming patent expirations of blockbuster drugs. In this environment global collaborations are increasing while budgets are shrinking, and as a result Internet-based communication has taken a prominent position in clinical development.
In contrast to the rapid changes in the structure of development teams and the advancements in web-based communications tools, the progress toward completely paperless clinical trials has been notably slow. Are we about to turn the corner and see new momentum? In over two decades since the first remote data entry systems were introduced, interfaces and speed of computer-based systems have improved greatly, yet the challenges of managing the paper distribution, collection and management of clinical regulatory documents in clinical trials persists.
Discussion includes:
In contrast to the rapid changes in the structure of development teams and the advancements in web-based communications tools, the progress toward completely paperless clinical trials has been notably slow. Are we about to turn the corner and see new momentum? In over two decades since the first remote data entry systems were introduced, interfaces and speed of computer-based systems have improved greatly, yet the challenges of managing the paper distribution, collection and management of clinical regulatory documents in clinical trials persists.
Discussion includes:
- The push for paperless continues: A look at the latest trends and initiatives
- Clinical studies end-to-end: Which parts of the process are farthest along and which have the highest hurdles
- Who benefits? Views on the benefits and burdens of transitioning to paperless for sites, sponsors, regulators and others
- Where from here? Practical next steps towards the paperless trial
More Webcasts
Live Panel Discussion Replay: The Globalization of Clinical Trials - The Good, The Bad & The Overall Impact on Pharma Development
The last decade has seen the proliferation of multinational clinical trials having sites in six or more countries, often spanning two or even three continents. The expansion of clinical trials to previously untapped locations has had many benefits:
- Improved ability to maintain strong recruitment rates
- Advanced capability to file/launch a new drug in many markets quickly
Live Webcast Replay: Better Execution, Earlier: Accelerating Deal Preparation and Pre-Due Diligence
Learn how leveraging the IntraLinks Deal Team Exchange can make the deal process faster, more efficient, and less cumbersome. In this interactive webcast, our sales engineer walks you through how using a Deal Team Exchange can get the team up and running to keep the process on track. This includes a deep dive in the key functionality for accelerating deal preparation and pre-due diligence.
Interview: Thomas Sabatino at the Argyle Chief Legal Officer Forum
Tom Sabatino delivered a keynote speech on the need for tighter integration between corporate legal teams and their law firms. In our interview with Tom, he further emphasized that collaboration is the foundation for effective management of legal departments, and that technology like IntraLinks can significantly enhance this process. See Tom's insight here.
Podcast: Inside The Records Room with Bob Little from AIIM's Info360 Conference
Bob Little, Vice President of Product Marketing at IntraLinks is interviewed by Ray Davis and Jeff Glover from Inside The Records Room at AIIM's Info360 Conference in Philadelphia, Pennsylvania. Bob and Ray discuss issues related to content and collaboration.
Protecting Your Fund: Complying with MA 201 CMR 17
MA 201 CMR 17 is the new Massachusetts privacy law which went into effect March 1st, 2010. Industry occurrences are now driving regulation, not just in Massachusetts, but throughout the country. More than 260 million records containing personal sensitive information have been involved in security breaches in the United States since January 2005. In Massachusetts alone, in a ten month period concluding in 2008, more than 600,000 Massachusetts residents were affected by breaches. The negative effect of data breaches is real, and happens to businesses of all sizes, and not just those that are based in Massachusetts. This Webcast speaks broadly about the risks faced by organizations.
Did You Know?
IntraLinks also offers:
Success Story
immatics biotechnologies
Cancer drug developer immatics biotechnologies prides itself on open communication. Using IntraLinks to manage due diligence, immatics showed investors they could trust the company. What resulted was the largest private biotech financing round in Germany since 2001. In the process, immatics saved time and resources, and gave investors an efficient way to review information.